US Patent Issued to National University Corporation Tottori University, Evolve Biotherapeutics on Sept. 9 for "Vaccinia virus that induces cell fusion and use thereof" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,198, issued on Sept. 9, was assigned to National University Corporation Tottori University (Tottori, Japan) and Evolve Biotherapeutics Co. Ltd. (Yonago, Japan).

"Vaccinia virus that induces cell fusion and use thereof" was invented by Takafumi Nakamura (Yonago, Japan), Nozomi Kuwano (Yonago, Japan), Motomu Nakatake (Yonago, Japan) and Hajime Kurosaki (Yonago, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a vaccinia virus that induces cell fusion between infected cells and a method for producing the same. Such vaccinia virus is deprived of the K2L gene or the HA gene or functions of the K2L gene and the HA gene and is ...